Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
about
The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis.Treatment of post-traumatic hand Staphylococcus aureus osteomyelitis with oral linezolid.Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolidEfficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: a case-control study.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Linezolid for the treatment of drug-resistant infections.A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureusThe safety and efficacy of linezolid in orthopaedic practice for the treatment of infection due to antibiotic-resistant organisms.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Role of linezolid in the treatment of orthopedic infections.Update on linezolid: the first oxazolidinone antibiotic.Experimental osteomyelitis: what have we learned from animal studies about the systemic treatment of osteomyelitis?Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Early and extended early bactericidal activity of linezolid in pulmonary tuberculosisA case of hypersensitivity syndrome to both vancomycin and teicoplanin.Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.Treatment of prosthetic osteoarticular infections.Medical management of diabetic foot infections.The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.Linezolid Treatment for Osteomyelitis due to Staphylococcus Epidermidis with Reduced Vancomycin Susceptibility.Systemic antimicrobial therapy in osteomyelitisPenetration of linezolid into rabbit intervertebral discs and surrounding tissues.Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.Ceftobiprole: First reported experience in osteomyelitis.Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus.Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model.Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Septic arthritis of the sacroiliac joint.Treatment recommendations and strategies for the management of bone and joint infections
P2860
Q33370027-35C7554A-EEB2-488D-8E39-2C2CC7D23F0EQ33372884-510B97D1-0141-43AE-91D3-5CD2B7AAA213Q33375091-F0B986AC-0754-4B1A-9556-AFAA549C41BEQ33384409-9F53BB27-BD59-4FA1-9EE1-5BB144689492Q34157657-713F2A30-BE2D-4F08-9AA5-76B1F7CE6EE2Q34894133-DB7260FB-F5C9-4609-BC8B-8BCCB778EBACQ35745670-34335CE4-19DE-418D-8FF4-B6C7D17778FFQ35873712-5494D0FD-9325-4907-A45D-4CC1788F63AAQ36083208-F54A74F2-8630-44D8-ADDC-071112A96C76Q36162348-730CA470-9690-48F5-8EA5-F0CC65CF6192Q36283744-EF5F272D-7879-4FB6-94F9-F39235417985Q36664067-55941796-6923-4320-A216-F99F7847D83DQ36718474-CC7591BE-337B-4902-BF45-CD085A82C128Q36986669-5C0A46CF-F32B-4F3E-8135-4C8EA904779BQ37292097-3AD7DB81-EEED-43C1-988F-816AC3B1C35AQ37333092-5DF6E16D-1540-465E-A3FC-7D51EDD6D584Q37853179-4CFC56E0-34BA-4526-8E13-AA00C54E2F49Q37995865-72018011-2B8F-448C-98F5-DC0FC8D9F77EQ38084726-9535153C-A1E2-4D9C-86BC-27F4CD254BB1Q38929509-29C1B0D8-CDA7-4CAA-8681-15312CCE46B9Q40401780-10FCA41F-2642-442D-AAFF-EB0B4A3B8B43Q41034745-A12FF099-F81B-4482-8465-53EF00F157F0Q41214227-A9F6974F-FF4E-4F01-BB6F-0C4CE81DFCC2Q41589621-F345225D-EBDD-4628-A0B8-035C1FECFF26Q42412528-67ADCC68-9DB5-4B17-8C1D-3E6F027A7E72Q43183402-77DA0F22-8211-40F8-8085-575E8457228FQ44769624-47AD00E0-002F-43FD-BEC3-E938C416E6EEQ45258208-0C12A6D8-D0AB-4BDA-81D8-D6F54E7DA7D3Q46837532-E13B4BDF-CD8E-4502-ACDE-A4EA3229082CQ47611899-173BFE65-4D66-4876-984B-77699B4D9D67Q55046518-EEBAD468-3820-4D07-929A-C2DDF81B072DQ58405400-0D7C47BC-4E26-407D-8586-3C872B8AE3B1
P2860
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@en
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@nl
type
label
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@en
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@nl
prefLabel
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@en
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@nl
P2093
P1433
P1476
Linezolid in the treatment of osteomyelitis: results of compassionate use experience.
@en
P2093
Baddour LM
Birmingham MC
Meagher AK
Schentag JJ
P2888
P356
10.1007/S15010-004-3029-9
P577
2004-02-01T00:00:00Z